Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020

BACKGROUND: Rheumatologists must contend with COVID-19 pandemic in the management of their patients and many questions have been raised on the use of both anti-inflammatory drugs and disease-modifying anti-rheumatic drugs (DMARD). The French Society of Rheumatology (SFR) selected the most critical o...

Descripción completa

Detalles Bibliográficos
Autores principales: Richez, Christophe, Flipo, René-Marc, Berenbaum, Francis, Cantagrel, Alain, Claudepierre, Pascal, Debiais, Françoise, Dieudé, Philippe, Goupille, Philippe, Roux, Christian, Schaeverbeke, Thierry, Wendling, Daniel, Pham, Thao, Thomas, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de rhumatologie. Published by Elsevier Masson SAS. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255274/
https://www.ncbi.nlm.nih.gov/pubmed/32473418
http://dx.doi.org/10.1016/j.jbspin.2020.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255274/
https://www.ncbi.nlm.nih.gov/pubmed/32473418
http://dx.doi.org/10.1016/j.jbspin.2020.05.006

Ejemplares similares